-transparent.png){kind=logo}
The effects of benzoflavones on skin tumor initiation by polycyclic hydrocarbons and epidermal aryl hydrocarbon hydroxylase were investigated. 7,8-Benzoflavone (7,8-BF) was found to be a potent inhibitor of the inhibition of skin tumors by 3-methylcholanthrene (MC) as well as 7,12-dimethylbenz(a)anthracene (DMBA). 5,6-Benzoflavone(5,6-BF) inhibited tumor initiation by MC and DMBA, but to a lesser degree than 7,8-BF. Dose-response studies of the capacity of 7,8-BF to inhibit DMBA tumor initiation revealed that 7,8-BF was an effective inhibitor at 2.5 microgram and a maximum inhibition of 90% occurred at 100 microgram of 7,8-FB. The tumor initiating ability of 7-hydroxymethyl-12-methylbenz(a)anthracene (7-OHMe-12MeBA) was not inhibited by 7,8-BF. Epidermal aryl hydrocarbon(benzo(a)pyrene hydroxylase(AHH) was increased by 5,6-BF and either had no effect or was slightly inhibited by 7,8-BF when given either topically or i.p. Both flavones when added directly to the assay tubes inhibited the in vitro epidermal AHH activity from control and MC pretreated mice by greater than 75%. When added in vitro, 7,8-BF and 5,6-BF inhibited epidermally mediated covalent binding of radioactive DMBA and dibenz(a,h)anthracene to DNA by 50% or more. The inhibition of skin tumor initiation by 7,8-BF and 5,6-BF appears to be partially related to its ability to inhibit the formation of electrophilic intermediates.
T J Slaga, and
S Thompson, and
D L Berry, and
J Digiovanni, and
M R Juchau, and
A Viaje
April 1972,
Cancer research,
T J Slaga, and
S Thompson, and
D L Berry, and
J Digiovanni, and
M R Juchau, and
A Viaje
June 1977,
Cancer research,
T J Slaga, and
S Thompson, and
D L Berry, and
J Digiovanni, and
M R Juchau, and
A Viaje
February 1977,
Research communications in chemical pathology and pharmacology,
T J Slaga, and
S Thompson, and
D L Berry, and
J Digiovanni, and
M R Juchau, and
A Viaje
February 1989,
Carcinogenesis,
T J Slaga, and
S Thompson, and
D L Berry, and
J Digiovanni, and
M R Juchau, and
A Viaje
January 1982,
Carcinogenesis,
T J Slaga, and
S Thompson, and
D L Berry, and
J Digiovanni, and
M R Juchau, and
A Viaje
January 1980,
Advances in enzyme regulation,
T J Slaga, and
S Thompson, and
D L Berry, and
J Digiovanni, and
M R Juchau, and
A Viaje
June 1979,
Cancer letters,
T J Slaga, and
S Thompson, and
D L Berry, and
J Digiovanni, and
M R Juchau, and
A Viaje
January 1974,
Advances in cancer research,
T J Slaga, and
S Thompson, and
D L Berry, and
J Digiovanni, and
M R Juchau, and
A Viaje
August 1980,
Cancer research,
T J Slaga, and
S Thompson, and
D L Berry, and
J Digiovanni, and
M R Juchau, and
A Viaje
June 2008,
Cancer letters,
